Juan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Juan Li has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Shunxiang Li
School of Pharmacy, Hunan University of Chinese Medicine
5 shared publications Jie Ren
School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, PR China
3 shared publicationsAiqing Fang
School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, PR China
1 shared publication- Bin Li
Hunan University of Chinese Medicine
1 shared publication Bo Xu
Hunan Province Engineering Research Center of Bioactive Substance Discovery of TCM, Hunan University of Chinese Medicine, Changsha, 410208, P. R. China
1 shared publication- Fang Liu
School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China; Center for Standardization and Functional Engineering of Traditional Chinese Medicine in Hunan Province, Changsha, 410208, China; Key Laboratory of Modern Research of TCM, Education Department of Hunan Province, Changsha, 410208, China
1 shared publication
Latest Publications
- Open Access
- 13 August 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (8) , 1063
Unearthing the Potential Therapeutic Effects of Oxyresveratrol Based on Intrinsic Links between Pharmacological Effects: Implications for the Gut–Liver–Brain Axis
Oxyresveratrol is a stilbene compound with a simple chemical structure and various therapeutic potentials. This study summarized and analyzed the multiple pharmacological effects and mechanisms of oxyresveratrol, identifying its prominent performance in neuroprotection, hepatoprotection, and anti-inflammatory activities in the intestines. By integrating the pharmacological effects of oxyresveratrol with insights from the network pharmacology and molecular docking of its interactions with targets linked to gut–liver–brain axis disorders, it has been shown that oxyresveratrol may hold promise for the treatment of gut–liver–brain axis-related disorders. The synergistic effect between various mechanisms has inspired further research and the development of oxyresveratrol’s application value.
- 13 August 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (8) , 1063
Open AccessUnearthing the Potential Therapeutic Effects of Oxyresveratrol Based on Intrinsic Links between Pharmacological Effects: Implications for the Gut–Liver–Brain Axis
Oxyresveratrol is a stilbene compound with a simple chemical structure and various therapeutic potentials. This study summarized and analyzed the multiple pharmacological effects and mechanisms of oxyresveratrol, identifying its prominent performance in neuroprotection, hepatoprotection, and anti-inflammatory activities in the intestines. By integrating the pharmacological effects of oxyresveratrol with insights from the network pharmacology and molecular docking of its interactions with targets linked to gut–liver–brain axis disorders, it has been shown that oxyresveratrol may hold promise for the treatment of gut–liver–brain axis-related disorders. The synergistic effect between various mechanisms has inspired further research and the development of oxyresveratrol’s application value.
- 12 December 2023
- Published by Elsevier in Fitoterapia
- Vol. 172, 105774
Lignans from the leaves of Styrax japonicus and their anti-inflammatory activity
- 12 December 2023
- Published by Elsevier in Fitoterapia
- Vol. 172, 105774
Lignans from the leaves of Styrax japonicus and their anti-inflammatory activity
- Open Access
- 25 August 2022
- Published by Wiley in Journal of Analytical Methods in Chemistry
- Vol. 2022 (1) , 8042631
Quantitative Analysis of Berberidis Cortex via Quantitative Analysis of Multicomponents by Single Marker (QAMS) Combined with Fingerprint and Chemometrics Methods
Berberidis Cortex is rich in alkaloids, and many of them have antibacterial, anti‐inflammatory, and hypoglycemic activities. However, few research studies have focused on the quantitative analysis of multiple components from Berberidis Cortex. In this study, a new quality evaluation strategy for Berberidis Cortex was developed and validated by high‐performance liquid chromatography (HPLC), which involved single marker, fingerprint, and stoichiometric methods. Using berberine hydrochloride as an internal reference, the relative correction factors of palmatine hydrochloride, magnoline, and jatrorrhizine hydrochloride were 2.4537, 0.9783, and 1.0035, respectively, and their durabilities were also well performed. In addition, both methods mentioned above were used to compare the mass fractions of four isoquinoline alkaloids in ten batches of Berberidis Cortex from different origins. These results indicated that the approach applied in this study was accurate and feasible. The fingerprints of these ten batches of Berberidis Cortex were established, and eleven components were identified with the similarity greater than 0.993. Both cluster and principal component analysis were carried out based on the peak area of these components, the results demonstrated that these ten batches of Berberidis Cortex were divided into two groups and the distribution of the medicinal material was basically consistent. Therefore, quantitative analysis of multicomponents by single marker (QAMS) can be widely used in the quality control of Berberidis Cortex as theoretical basis.
- 25 August 2022
- Published by Wiley in Journal of Analytical Methods in Chemistry
- Vol. 2022 (1) , 8042631
Open AccessQuantitative Analysis of Berberidis Cortex via Quantitative Analysis of Multicomponents by Single Marker (QAMS) Combined with Fingerprint and Chemometrics Methods
Berberidis Cortex is rich in alkaloids, and many of them have antibacterial, anti‐inflammatory, and hypoglycemic activities. However, few research studies have focused on the quantitative analysis of multiple components from Berberidis Cortex. In this study, a new quality evaluation strategy for Berberidis Cortex was developed and validated by high‐performance liquid chromatography (HPLC), which involved single marker, fingerprint, and stoichiometric methods. Using berberine hydrochloride as an internal reference, the relative correction factors of palmatine hydrochloride, magnoline, and jatrorrhizine hydrochloride were 2.4537, 0.9783, and 1.0035, respectively, and their durabilities were also well performed. In addition, both methods mentioned above were used to compare the mass fractions of four isoquinoline alkaloids in ten batches of Berberidis Cortex from different origins. These results indicated that the approach applied in this study was accurate and feasible. The fingerprints of these ten batches of Berberidis Cortex were established, and eleven components were identified with the similarity greater than 0.993. Both cluster and principal component analysis were carried out based on the peak area of these components, the results demonstrated that these ten batches of Berberidis Cortex were divided into two groups and the distribution of the medicinal material was basically consistent. Therefore, quantitative analysis of multicomponents by single marker (QAMS) can be widely used in the quality control of Berberidis Cortex as theoretical basis.
- 11 July 2017
- Published by Wiley in Chemistry & Biodiversity
- Vol. 14 (10)
A Novel Tropoloisoquinoline Alkaloid, Neotatarine, from Acorus calamus L.
A novel tropoloisoquinoline alkaloid, neotatarine (1), was isolated from the 95% ethanol extract of the rhizome parts of Acorus calamus L. The chemical structure was unambiguously elucidated by spectroscopic and single‐crystal X‐ray diffraction analysis. Neotatarine (1) exhibited significantly inhibitory activity against Aβ25 – 35 induced PC12 cell death with 2, 4 and 8 μm comparing with the assay control (P < 0.01).
- 11 July 2017
- Published by Wiley in Chemistry & Biodiversity
- Vol. 14 (10)
A Novel Tropoloisoquinoline Alkaloid, Neotatarine, from Acorus calamus L.
A novel tropoloisoquinoline alkaloid, neotatarine (1), was isolated from the 95% ethanol extract of the rhizome parts of Acorus calamus L. The chemical structure was unambiguously elucidated by spectroscopic and single‐crystal X‐ray diffraction analysis. Neotatarine (1) exhibited significantly inhibitory activity against Aβ25 – 35 induced PC12 cell death with 2, 4 and 8 μm comparing with the assay control (P < 0.01).
- Open Access
New Acorane-Type Sesquiterpene from Acorus calamus L.
A new sesquiterpene, named neo-acorane A (1), and two known ones, acoric acid (2) and calamusin D (3), were isolated from a 95% ethanol extract of the rhizome parts of Acorus calamus L. Their structures were elucidated by spectroscopic methods, and the absolute configurations were determined by single-crystal X-ray diffraction analysis. Compounds 1 and 2 are nonisoprenoid sesquiterpenoids, likely biosynthesized from an acorane-type sesquiterpene by oxidative fission of the six- or five-membered ring. Moreover, compounds 1 (10 μM), 2 (5 μM and 10 μM) and 3 (10 μM) showed cell proliferation activity on the SK-N-BE (2) cell line.
Open AccessNew Acorane-Type Sesquiterpene from Acorus calamus L.
A new sesquiterpene, named neo-acorane A (1), and two known ones, acoric acid (2) and calamusin D (3), were isolated from a 95% ethanol extract of the rhizome parts of Acorus calamus L. Their structures were elucidated by spectroscopic methods, and the absolute configurations were determined by single-crystal X-ray diffraction analysis. Compounds 1 and 2 are nonisoprenoid sesquiterpenoids, likely biosynthesized from an acorane-type sesquiterpene by oxidative fission of the six- or five-membered ring. Moreover, compounds 1 (10 μM), 2 (5 μM and 10 μM) and 3 (10 μM) showed cell proliferation activity on the SK-N-BE (2) cell line.
- 11 November 2015
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 51 (6) , 1099-1102
A New Sesquiterpene from Acorus calamus Rhizoma
- 11 November 2015
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 51 (6) , 1099-1102
A New Sesquiterpene from Acorus calamus Rhizoma